Smolen, J. S., Aletaha, D. & McInnes, I. B. Rheumatoid arthritis. Lancet 388, 2023–2038 (2016).
Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094–1108 (2010).
Garrod, A. E. A Treatise on Rheumatism and Rheumatoid Arthritis (Griffin’s Medical Series, 1890).
Shlobin, N. A. & Dahdaleh, N. S. Cervical spine manifestations of rheumatoid arthritis: A review. Neurosurg. Rev. 44, 1957–1965 (2021).
Kim, H. J., Nemani, V. M., Riew, K. D. & Brasington, R. Cervical spine disease in rheumatoid arthritis: Incidence, manifestations, and therapy. Curr. Rheumatol. Rep. 17, 9 (2015).
Chattopadhyay, A., Samanta, J., Jindal, A. & Jain, S. Neck pain in rheumatoid arthritis: A look beyond cervical spine involvement. Rheumatology (Oxford) 60, 471 (2021).
Carotti, M., Salaffi, F., Di Carlo, M., Sessa, F. & Giovagnoni, A. Magnetic resonance imaging of the craniovertebral junction in early rheumatoid arthritis. Skelet. Radiol. 48, 553–561 (2019).
Drosos, A. A., Pelechas, E. & Voulgari, P. V. Radiological findings of the cervical spine in rheumatoid arthritis: What a rheumatologist should know. Curr. Rheumatol. Rep. 22, 19 (2020).
Kaito, T. et al. Incidence and risk factors for cervical lesions in patients with rheumatoid arthritis under the current pharmacologic treatment paradigm. Mod. Rheumatol. 27, 593–597 (2017).
Montemerani, M. et al. Involvement of atlanto-axial joint in rheumatoid arthritis: Rare or frequent?. Clin. Rheumatol. 13, 459–463 (1994).
Zhang, T. & Pope, J. Cervical spine involvement in rheumatoid arthritis over time: Results from a meta-analysis. Arthritis Res. Ther. 17, 148 (2015).
Aletaha, D. et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580–1588 (2010).
Duru, N. et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann. Rheum. Dis. 72, 1905–1913 (2013).
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R. & Feinstein, A. R. A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 49, 1373–1379 (1996).
Greenland, S., Schwartzbaum, J. A. & Finkle, W. D. Problems due to small samples and sparse data in conditional logistic regression analysis. Am. J. Epidemiol. 1(151), 531–539 (2000).
Joaquim, A. F., Ghizoni, E., Tedeschi, H., Appenzeller, S. & Riew, K. D. Radiological evaluation of cervical spine involvement in rheumatoid arthritis. Neurosurg. Focus 38, E4 (2015).
Castro, S. et al. Cervical spine involvement in rheumatoid arthritis: A clinical, neurological and radiological evaluation. Clin. Exp. Rheumatol. 12, 369–374 (1994).
Baek, I. W., Joo, Y. B., Park, K. S. & Kim, K. J. Risk factors for cervical spine instability in patients with rheumatoid arthritis. Clin. Rheumatol. 40, 547–555 (2021).
Kotecki, M., Gasik, R., Głuszko, P. & Sudoł-Szopińska, I. Radiological evaluation of cervical spine involvement in rheumatoid arthritis: A cross-sectional retrospective study. J. Clin. Med. 10, 4587 (2021).
Hyrich, K. L., Watson, K. D., Silman, A. J., Symmons, D. P., British Society for Rheumatology Biologics Register. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 45, 1558–1565 (2006).
Kvien, T. K., Uhlig, T., Ødegård, S. & Heiberg, M. S. Epidemiological aspects of rheumatoid arthritis: The sex ratio. Ann. N. Y. Acad. Sci. 1069, 212–222 (2006).
Mancarella, L. et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: The GISEA study. J. Rheumatol. 34, 1670–1673 (2007).
Kocijan, R., Harre, U. & Schett, G. ACPA and bone loss in rheumatoid arthritis. Curr. Rheumatol. Rep. 15, 366 (2013).
Katchamart, W., Koolvisoot, A., Aromdee, E., Chiowchanwesawakit, P. & Muengchan, C. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatol. Int. 35, 1693–1699 (2015).
Symmons, D. et al. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs—Results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) 45, 558–565 (2006).
Turesson, C. Extra-articular rheumatoid arthritis. Curr. Opin. Rheumatol. 25, 360–366 (2013).
Conforti, A. et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun. Rev. 20, 102735 (2021).
Bruno, F. et al. New advances in MRI diagnosis of degenerative osteoarthropathy of the peripheral joints. Radiol. Med. 124, 1121–1127 (2019).
Østergaard, M. & Boesen, M. Imaging in rheumatoid arthritis: The role of magnetic resonance imaging and computed tomography. Radiol. Med. 124, 1128–1141 (2019).
Barile, A. et al. Computed tomography and MR imaging in rheumatoid arthritis. Radiol. Clin. North Am. 55, 997–1007 (2017).
Bruno, F. et al. MR imaging of the upper limb: Pitfalls, tricks, and tips. Radiol. Clin. North Am. 57, 1051–1062 (2019).
Buch, M. H. Defining refractory rheumatoid arthritis. Ann. Rheum. Dis. 77, 966–969 (2018).
Kauppi, M. J. et al. Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs. J. Rheumatol. 36, 273–278 (2009).
Kaito, T. et al. Effect of biological agents on cervical spine lesions in rheumatoid arthritis. Spine (Phila Pa 1976) 37, 1742–1746 (2012).
Kanayama, Y. et al. Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving infliximab treatment. Mod. Rheumatol. 20, 273–279 (2010).
Wasserman, B. R., Moskovich, R. & Razi, A. E. Rheumatoid arthritis of the cervical spine—Clinical considerations. Bull. NYU Hosp. Jt. Dis. 69, 136–148 (2011).
Cipriani, P. et al. Biologic therapies and infections in the daily practice of three Italian rheumatologic units: A prospective, observational study. Clin. Rheumatol. 36, 251–260 (2017).
Giacomelli, R. et al. Guidelines for biomarkers in autoimmune rheumatic diseases—Evidence based analysis. Autoimmun. Rev. 18, 93–106 (2019).
Giacomelli, R. et al. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren’s syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun. Rev. 16, 911–924 (2017).
Giacomelli, R. et al. The growing role of precision medicine for the treatment of autoimmune diseases; Results of a systematic review of literature and Experts’ Consensus. Autoimmun. Rev. 20, 102738 (2021).